Vaxart, Inc. Intangible Assets, Gross (Excluding Goodwill)
Vaxart, Inc. (VXRT) had Intangible Assets, Gross (Excluding Goodwill) of $14.40 million as of 2013-06-30, per its 10-K filed 2013-09-27.
Discontinued › Notes › Goodwill and Other
us-gaap:IntangibleAssetsGrossExcludingGoodwill · last filed 2013-09-27
- 2013-06-30: Intangible Assets, Gross (Excluding Goodwill) $14.40M.
- 2012-06-30: Intangible Assets, Gross (Excluding Goodwill) $15.60M.
| Period end | Intangible Assets, Gross (Excluding Goodwill) |
|---|---|
| 2013-06-30 | $14.40M 10-K · filed 2013-09-27 |
| 2012-06-30 | $15.60M 10-K · filed 2013-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |